Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Karyopharm Therapeutics (KPTI) Tax Rate (2017 - 2025)

Karyopharm Therapeutics (KPTI) has disclosed Tax Rate for 9 consecutive years, with 0.22% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate fell 4.0% year-over-year to 0.22%, compared with a TTM value of 0.09% through Dec 2025, up 15.0%, and an annual FY2025 reading of 1.19%, down 7244.0% over the prior year.
  • Tax Rate was 0.22% for Q4 2025 at Karyopharm Therapeutics, up from 0.13% in the prior quarter.
  • Across five years, Tax Rate topped out at 0.28% in Q2 2024 and bottomed at 0.39% in Q2 2023.
  • Average Tax Rate over 5 years is 0.14%, with a median of 0.2% recorded in 2021.
  • Peak annual rise in Tax Rate hit 68bps in 2021, while the deepest fall reached -14bps in 2021.
  • Year by year, Tax Rate stood at 0.31% in 2021, then increased by 14bps to 0.27% in 2022, then rose by 6bps to 0.26% in 2023, then surged by 204bps to 0.27% in 2024, then dropped by -16bps to 0.22% in 2025.
  • Business Quant data shows Tax Rate for KPTI at 0.22% in Q4 2025, 0.13% in Q3 2025, and 0.27% in Q4 2024.